Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sandoz Incorporated
WARNING LETTER
•Sandoz Incorporated•August 4, 2011

Sandoz Incorporated – FDA Warning Letter, Aug 4, 2011

Record Details

The FDA issued a Warning Letter to Novartis International AG on November 18, 2011, following inspections of its Sandoz pharmaceutical manufacturing facilities in Broomfield, Colorado; Wilson, North Carolina; and Boucherville, Quebec, Canada, conducted from April to August 2011. The inspections revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211), rendering drug products adulterated.

Key violations at Sandoz Canada Inc. (Boucherville) included: - **Microbiological Contamination Prevention (21 CFR § 211.113(b)):** Insufficient media fill studies with inconsistent and inaccurate reconciliation of filled vials, a repeat observation from July 2009. - **Investigation of Batch Failures (21 CFR § 211.192):** Inadequate investigation into crystallization of (b)(4) Injectable, with 62.5% of reviewed lots showing crystals, and failure to determine the root cause or implement effective corrective actions. This was also a repeat observation. - **Component Testing (21 CFR § 211.84(d)(2)):** Reliance on supplier's Certificate of Analysis for stoppers without adequate vendor qualification or routine endotoxin testing, a repeat observation. - **Field Alert Report (FAR) Violations (21 CFR §

Company
Sandoz Incorporated
Inspection date
August 4, 2011
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald DeGolyer
  • Khalid Nasim
  • Jon Rushord
  • Yves Moinard
  • Steven J. Lynn
View Company Profile

ID · 3327275e-804f-4ed6-89f6-a334d647c9e3

Violation Codes10
21 CFR 21021 CFR 21121 CFR 314.81(b)(1)(ii)21 CFR 211.113(b)21 CFR 211.19221 CFR 211.84(d)(2)21 CFR 211.100(a)21 CFR 211.67(a)21 U.S.C. 355(k)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sandoz Incorporated
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.